文献速递流行病学与生物统计医学教育与科研方法

模拟目标试验的观察性研究的透明报告:TARGET声明

Transparent reporting of observational studies emulating a target trial: the TARGET Statement.
PubMed 文献 · BMJ · 2025-09-03

TARGET指南依EQUATOR框架制定,含系统综述、两轮在线调查、三日专家共识会及108名利益相关者试点,最终形成21条清单,分摘要、引言、方法、结果、讨论、其他信息六部分,用于报告通过显式模拟目标试验估计因果效应的观察性研究。

要点

  • TARGET清单共21条,分六部分,指导模拟目标试验的观察性研究报告。
  • 关键推荐包括标明研究为观察性模拟、概述因果问题及模拟理由。
  • 需明确目标试验方案(因果估计量、识别假设、分析计划)及其映射方式。

核心结论

  • 应用TARGET指南推荐旨在提高报告透明度和同行评议质量,帮助研究者、临床医生和其他读者解读与应用结果。

研究设计与样本

  • TARGET指南采用EQUATOR框架制定,包括对已发表显式模拟目标试验研究的报告实践进行系统综述。
  • 开展两轮在线调查(2023年8月至2024年3月;来自六个国家的18名专家参与),评估候选条目重要性并识别新条目。
  • 举行三日专家共识会议(2024年6月;18名专家组成员),细化指南范围并起草清单。
  • 与利益相关者(n=108;2024年9月至2025年2月)对清单草案进行试点,并根据 successive drafts 的反馈进一步修订。

主要发现

  • 最终形成21条TARGET清单,组织为摘要、引言、方法、结果、讨论、其他信息六个部分。
  • TARGET为显式模拟平行组、个体随机目标试验并调整基线混杂因素的观察性干预研究提供报告指导。

关键数值与推荐

  • 关键推荐包括:将研究标识为观察性模拟目标试验。
  • 关键推荐包括:概述因果问题及模拟目标试验的理由。
  • 关键推荐包括:明确目标试验方案(即因果估计量、识别假设、数据分析计划)及其如何映射到观察性数据。
  • 关键推荐包括:报告每个因果估计量获得的估计值、其精度,以及评估估计值对假设、设计和分析选择敏感性的附加分析结果。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: When randomized trials are unavailable or not feasible, observational studies can be used to answer causal questions about the comparative effects of interventions by attempting to emulate a hypothetical pragmatic randomized trial (target trial). Published guidance to aid reporting of these studies is not available. OBJECTIVE: To develop consensus based guidance for reporting observational studies performed to estimate causal effects by explicitly emulating a target trial. DESIGN, SETTING, AND PARTICIPANTS: The Transparent Reporting of Observational Studies Emulating a Target Trial (TARGET) guideline was developed using the Enhancing the Quality and Transparency of Health Research (EQUATOR) framework. The development included (1) a systematic review of reporting practices in published studies that had explicitly aimed to emulate a target trial; (2) a two round online survey (August 2023 to March 2024; 18 expert participants from six countries) to assess the importance of candidate items selected from previous research and to identify additional items; (3) a three day, expert consensus meeting (June 2024; 18 panelists) to refine the scope of the guideline and draft the checklist; and (4) pilot of the draft checklist with stakeholders (n=108; September 2024 to February 2025). The checklist was further refined based on feedback on successive drafts. FINDINGS: The 21-item TARGET checklist is organized into six sections (abstract, introduction, methods, results, discussion, other information). TARGET provides guidance for reporting observational studies of interventions explicitly emulating a parallel group, individually randomized target trial, with adjustment for baseline confounders. Key recommendations are to (1) identify the study as an observational emulation of a target trial; (2) summarize the causal question and reason for emulating a target trial; (3) clearly specify the target trial protocol (ie, the causal estimand, identifying assumptions, data analysis plan) and how it was mapped to the observational data; and (4) report the estimate obtained for each causal estimand, its precision, and findings from additional analyses to assess the sensitivity of the estimates to assumptions, and design and analysis choices. CONCLUSIONS AND RELEVANCE: Application of the TARGET guideline recommendations aims to improve reporting transparency and peer review and help researchers, clinicians, and other readers interpret and apply the results.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Cashin AG, Hansford HJ, Hernán MA, et al. Transparent reporting of observational studies emulating a target trial: the TARGET Statement. BMJ. 2025. PMID: 40903028. doi:10.1136/bmj-2025-087179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。